TNFSF10 and coronary artery disorder: The mean TRAIL concentration was ~30% lower in the STEMI cohort compared to patients with no detectable CAD (39.2 pg/mL ± 20.2 pg/mL vs. 55.8 pg/mL ± 21.8 pg/mL, p < 0.001).